ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

China cannot win the great vaccine diplomacy game without vaccines

Beijing's early advantages in supply, speed and demand are slipping

| China
A worker unloads a box of Sinovac Biotech's vaccines from a Chinese military aircraft at Villamor Air Base in Pasay, Metro Manila, on Feb. 28: China's greatest advantage in vaccine diplomacy is its speed.   © Reuters

Samantha Kiernan is a research associate on global health, economics and development at the Council on Foreign Relations. Yanzhong Huang is a senior fellow for global health at the Council on Foreign Relations and a professor at Seton Hall University's School of Diplomacy and International Relations.

At a glance, Beijing is winning at early vaccine diplomacy, as far as projecting soft power and expanding international influence is concerned. China has sent 114 million doses overseas and is out-pledging India, Russia and wealthy democracies in bilateral donations.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more